Sensitive Estrogen Detection Method Developed
By LabMedica International staff writers Posted on 13 Jan 2015 |
The hormone estrogen plays an important role in the human body and has been linked to everything from tumor growth to neuron loss during Alzheimer's disease, but detecting very small amounts of it in blood and other biological fluids can be difficult, especially in the limited amounts available in laboratory studies.
A new method for detecting trace amounts of estrogen has been developed that uses liquid chromatography-mass spectrometry (LC-MS) and tandem mass spectrometry (LC-MS/MS) which remains the most sensitive and specific technique for both quantitative and qualitative analysis of small molecules in biological samples.
Scientists at the University of Texas (Arlington, TX, USA) developed a method for ultra-trace determination of estrogens in human serum using a combination of charged bulk derivatization and weak cation exchange (WCX) RAM-based trap-and-elute LC–MS/MS. The LC system was equipped with four pumps (Pump A/B: LC-30AD, Pump C/D: LC-20AD XR), a SIL-30AC AS, and a CTO-30A column oven containing a 2-position six-port switching valve. The analyses have been performed with a prototype WCX RAM trap column (Shimadzu Corporation; Kyoto, Japan). The LC–MS/MS analysis was performed on a Shimadzu LCMS-8050 triple quadrupole mass spectrometer.
Mass spectrometry and chromatography are ways to separate, identify, and quantify molecules in a complex mixture. The process involving liquid chromatography-electrospray ionization-tandem mass spectrometry relies on a vital step called charge derivatization or using a permanently charged reagent to selectively trap the estrogens and isolate them from the lipids and proteins that could interfere with estrogen detection. The limits of detection (LODs) in the study were found to be 3 pg/mL for estriol, 7 pg/mL for estrone and 17α-estradiol, and 5 pg/mL for 17β-estradiol. The new method can be accomplished in less than 25 minutes, including sample preparation and was a sensitive and efficient method for detecting trace amounts at less than 10 parts per trillion in a 100 mL sample.
Jose A. Barrera, PhD, director of the Shimadzu Institute and a coauthor of the study, said, “This new method pushes the detection limit for estrogens to a level that is applicable to research, human health, medicine, and environmental analysis. Its being instituted as a routine service means that all scientists now have the capability to more closely relate research model findings to human health and physiology.” The study was published on November 27, 2014, in the journal Analytica Chimica Acta.
Related Links:
University of Texas
Shimadzu Corporation
A new method for detecting trace amounts of estrogen has been developed that uses liquid chromatography-mass spectrometry (LC-MS) and tandem mass spectrometry (LC-MS/MS) which remains the most sensitive and specific technique for both quantitative and qualitative analysis of small molecules in biological samples.
Scientists at the University of Texas (Arlington, TX, USA) developed a method for ultra-trace determination of estrogens in human serum using a combination of charged bulk derivatization and weak cation exchange (WCX) RAM-based trap-and-elute LC–MS/MS. The LC system was equipped with four pumps (Pump A/B: LC-30AD, Pump C/D: LC-20AD XR), a SIL-30AC AS, and a CTO-30A column oven containing a 2-position six-port switching valve. The analyses have been performed with a prototype WCX RAM trap column (Shimadzu Corporation; Kyoto, Japan). The LC–MS/MS analysis was performed on a Shimadzu LCMS-8050 triple quadrupole mass spectrometer.
Mass spectrometry and chromatography are ways to separate, identify, and quantify molecules in a complex mixture. The process involving liquid chromatography-electrospray ionization-tandem mass spectrometry relies on a vital step called charge derivatization or using a permanently charged reagent to selectively trap the estrogens and isolate them from the lipids and proteins that could interfere with estrogen detection. The limits of detection (LODs) in the study were found to be 3 pg/mL for estriol, 7 pg/mL for estrone and 17α-estradiol, and 5 pg/mL for 17β-estradiol. The new method can be accomplished in less than 25 minutes, including sample preparation and was a sensitive and efficient method for detecting trace amounts at less than 10 parts per trillion in a 100 mL sample.
Jose A. Barrera, PhD, director of the Shimadzu Institute and a coauthor of the study, said, “This new method pushes the detection limit for estrogens to a level that is applicable to research, human health, medicine, and environmental analysis. Its being instituted as a routine service means that all scientists now have the capability to more closely relate research model findings to human health and physiology.” The study was published on November 27, 2014, in the journal Analytica Chimica Acta.
Related Links:
University of Texas
Shimadzu Corporation
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Clinical Chem. News
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
- New Blood Testing Method Detects Potent Opioids in Under Three Minutes
- Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step
- Pain-Free, Low-Cost, Sensitive, Radiation-Free Device Detects Breast Cancer in Urine
- Spit Test Detects Breast Cancer in Five Seconds
- Electrochemical Sensors with Next-Generation Coating Advances Precision Diagnostics at POC
- First-Of-Its-Kind Handheld Device Accurately Detects Fentanyl in Urine within Seconds
- New Fluorescent Sensor Array Lights up Alzheimer’s-Related Proteins for Earlier Detection
- Automated Mass Spectrometry-Based Clinical Analyzer Could Transform Lab Testing
- Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses
- Non-Invasive Sensor Monitors Changes in Saliva Compositions to Rapidly Diagnose Diabetes
- Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia
- Urine Test for Monitoring Changes in Kidney Health Markers Can Predict New-Onset Heart Failure
- AACC Releases Comprehensive Diabetes Testing Guidelines